89 related articles for article (PubMed ID: 21573383)
1. Prognostic value of serum pepsinogen levels in patients with gastric-carcinoma.
Maeda K; Chung Y; Onoda N; Nisimura S; Nitta A; Arimoto Y; Kato Y; Sowa M
Int J Oncol; 1993 Sep; 3(3):437-40. PubMed ID: 21573383
[TBL] [Abstract][Full Text] [Related]
2. [Evaluation of serum pepsinogen I and II of patients with gastric cancer].
Kimura Y; Fujii T; Hamamoto K; Miyagawa N; Tsuda K; Tanada S; Iio A
Kaku Igaku; 1989 Sep; 26(9):1127-33. PubMed ID: 2810910
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance in combined detection of serum pepsinogen I, pepsinogen II and carbohydrate antigen 242 in gastric cancer.
Yun L; Bin Z; Guangqi G; Ding L; Xingdang L; Biao H
Hepatogastroenterology; 2014; 61(129):255-8. PubMed ID: 24895832
[TBL] [Abstract][Full Text] [Related]
4. [Studies on the cut-off value of serum pepsinogen abnormality for screening chronic atrophic gastritis and gastric carcinoma].
Li YH; Zhang XH; Huang B; Wang JL; Mi JM; Shen HT; Zhang ZG; Yan X; Xing LX; Wang SJ
Zhonghua Liu Xing Bing Xue Za Zhi; 2006 Oct; 27(10):840-4. PubMed ID: 17343174
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of cutoff levels for screening of gastric cancer using serum pepsinogens and distributions of levels of serum pepsinogen I, II and of PG I/PG II ratios in a gastric cancer case-control study.
Aoki K; Misumi J; Kimura T; Zhao W; Xie T
J Epidemiol; 1997 Sep; 7(3):143-51. PubMed ID: 9337512
[TBL] [Abstract][Full Text] [Related]
6. [Clinical significance of the measurement of serum pepsinogen group I and II by enzyme-linked immunosorbent assay].
Matsumoto K; Hashimoto K; Samori T; Taniguchi M; Kotera K; Nishi S; Takatsuji M; Higashi K; Itoh K
Rinsho Byori; 1992 Sep; 40(9):977-81. PubMed ID: 1434035
[TBL] [Abstract][Full Text] [Related]
7. [Correlation of serum pepsinogen level and gastric mucosal changes of residents in the high incidence area of gastric cancer].
Zhang XH; Huang B; Wang JL; Li YH; Mi JM; Shen HT; Zhang ZG; Yan X; Xing LX; Wang SJ
Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):507-11. PubMed ID: 17147114
[TBL] [Abstract][Full Text] [Related]
8. Validity of serum pepsinogen levels and quininium resin test combined for gastric cancer screening.
Kim JR; Lee K; Jung WT; Lee OJ; Kim TH; Kim HJ; Lee JS; Passaro DJ
Cancer Detect Prev; 2005; 29(6):570-5. PubMed ID: 16289505
[TBL] [Abstract][Full Text] [Related]
9. Group I pepsinogen for early detection of gastric cancer recurrence after total gastrectomy.
Kodama M; Koyama K; Tsuburaya Y; Ishikawa K; Koyama H; Narisawa T; Uesaka Y
World J Surg; 1990; 14(1):94-9; discussion 99-100. PubMed ID: 2305591
[TBL] [Abstract][Full Text] [Related]
10. Pepsinogens I and II in carcinoma of the stomach: an immunohistochemical study.
Stemmermann GN; Samloff IM; Hayashi T
Appl Pathol; 1985; 3(3):159-63. PubMed ID: 3915949
[TBL] [Abstract][Full Text] [Related]
11. [An investigation of the factors influencing serum pepsinogen levels--sex, age, smoking, drinking].
Kitahara F; Kashiwagi A; Kanai T; Idesawa T; Takayama I; Yoda Y; Kobayashi K; Ootaka M; Shimazaki R; Sato T; Nakamura T; Kojima Y; Morozumi A; Akahane K; Fujino MA
Nihon Shokakibyo Gakkai Zasshi; 1996 Dec; 93(12):867-75. PubMed ID: 8986077
[TBL] [Abstract][Full Text] [Related]
12. Improvement in serum pepsinogens and gastrin in long-term monitoring after eradication of Helicobacter pylori: comparison with H. pylori-negative patients.
Ohkusa T; Miwa H; Nomura T; Asaoka D; Kurosawa A; Sakamoto N; Abe S; Hojo M; Terai T; Ogihara T; Sato N
Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 1():25-32. PubMed ID: 15298602
[TBL] [Abstract][Full Text] [Related]
13. [A clinical study of pepsinogen I and II producing gastric carcinomas].
Kodoi A; Haruma K; Yoshihara M; Shimamoto T; Watanabe C; Okamoto S; Kawaguchi H; Tari A; Sumii K; Kajiyama G
Nihon Shokakibyo Gakkai Zasshi; 1993 Dec; 90(12):2971-8. PubMed ID: 8283807
[TBL] [Abstract][Full Text] [Related]
14. Helicobacter pylori infection, but not mucosal atrophy, significantly affects serum pepsinogen level after gastric cancer surgery.
Onoda N; Katsuragi K; Maeda K; Sawada T; Wakasa K; Hirakawa K
Hepatogastroenterology; 2006; 53(70):619-23. PubMed ID: 16995475
[TBL] [Abstract][Full Text] [Related]
15. Elevated serum pepsinogens in chronic renal failure patients.
Nakahama H; Tanaka Y; Shirai D; Nishihara F; Takamitsu Y; Nakanishi T; Sugita M
Nephron; 1995; 70(2):211-6. PubMed ID: 7566306
[TBL] [Abstract][Full Text] [Related]
16. Clinical implications of serum pepsinogen and progastricsin in man.
Axelsson CK
Scand J Clin Lab Invest Suppl; 1992; 210():81-96. PubMed ID: 1455183
[TBL] [Abstract][Full Text] [Related]
17. The usefulness of gastric mass screening using serum pepsinogen levels compared with photofluorography.
Yoshihara M; Sumii K; Haruma K; Kiyohira K; Hattori N; Tanaka S; Kajiyama G; Shigenobu T
Hiroshima J Med Sci; 1997 Jun; 46(2):81-6. PubMed ID: 9232936
[TBL] [Abstract][Full Text] [Related]
18. Pepsinogens A and C: purification from human gastric mucosa and determination in serum by optimized radioimmunoassays.
Hengels KJ; Strohmeyer G
Z Gastroenterol; 1989 Aug; 27(8):406-11. PubMed ID: 2609705
[TBL] [Abstract][Full Text] [Related]
19. The correlation between histological gastritis staging- 'OLGA/OLGIM' and serum pepsinogen test in assessment of gastric atrophy/intestinal metaplasia in China.
Wang X; Lu B; Meng L; Fan Y; Zhang S; Li M
Scand J Gastroenterol; 2017 Aug; 52(8):822-827. PubMed ID: 28436254
[TBL] [Abstract][Full Text] [Related]
20. [Distribution of serum pepsinogen I, II values and their ratios in residents of a rural area].
Aoki K; Misumi J
Nihon Koshu Eisei Zasshi; 1993 Apr; 40(4):313-22. PubMed ID: 8329751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
